Henry Schein (HSIC) Launches BRIDGE Health Network, Is The Stock Still Undervalued?
Henry Schein (HSIC) just put dental offices at the center of broader health screening through the new BRIDGE Health Network, a pilot effort that incorporates point-of-care tests into routine hygiene visits.
Recent trading shows that Henry Schein’s 7 day share price return of 3.65% and 30 day gain of 3.99% sit against a year to date share price return of 15.10% and a 1 year total shareholder return of 20.56%. This suggests momentum has been building as investors react to steady earnings updates and the BRIDGE Health Network launch.
Scan for other health-focused distributors showing similar momentum and medical integration potential by lining up Henry Schein against our hand-picked 37 healthcare AI stocks list.
After a 1 year total return of just over 20% and fresh attention on BRIDGE, the key question now is simple: Does Henry Schein’s current valuation still leave enough potential upside to justify the risk you are taking on?
Most Popular Narrative: 9.9% Undervalued
On the analyst consensus Narrative on Simply Wall St, Henry Schein’s fair value sits at $98.19 compared with the last close of $88.42. This frames the BRIDGE Health Network story inside a broader margin and cash flow thesis that runs well beyond 2024 headlines.
The company is experiencing strong growth in high-margin businesses such as Specialty Products, Technology, and private-label offerings. It expects over 50% of non-GAAP operating income to come from these segments, supporting structurally higher gross margins and likely driving earnings expansion.
See why 7 investors see Henry Schein as 10% undervalued.
Result: Fair Value of $98.19 (UNDERVALUED)
Still, the Henry Schein story can change quickly if execution on the US$200 million efficiency plan slips, or if scanner pricing pressure continues to weigh on equipment margins.
Find out about the key risks to this Henry Schein narrative.
Next Steps
Mixed signals in Henry Schein’s story so far. Take a closer look at both sides of the ledger and pressure test your view with the 3 key rewards and 1 important warning sign
Looking for more investment ideas beyond Henry Schein?
Henry Schein may already be on your watchlist, but you can widen your opportunity set by lining it up against other targeted ideas from the Simply Wall St screener.
- Target resilient income by reviewing companies that qualify as 6 dividend fortresses and see which payouts look better suited to your goals.
- Hunt for quality at a potential discount by lining Henry Schein up against our curated universe of 32 high quality undervalued stocks.
- Reduce portfolio stress by comparing Henry Schein with a 30 resilient stocks with low risk scores that highlights businesses scoring well on financial risk checks.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com